Ohio State leading a national network to bring cancer clinical trials to patients
OSU as a Network Lead Academic Participating Site for the NCI NCTN
This program brings NCI-sponsored cancer clinical trials to adult patients at Ohio State so they can access new treatments and participate in research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11290630 on NIH RePORTER |
What this research studies
If you get cancer care at Ohio State, this program connects the center to the NCI's National Clinical Trial Network so local doctors can open and run national cancer trials here. A multidisciplinary team — including medical, surgical, and radiation oncologists, transplant specialists, pathologists, lab scientists, nurses, and research coordinators — manages trials, core labs, and sample testing. That lets patients enroll in trials for both blood cancers and solid tumors and allows researchers to study tumor samples and other biological markers. Participation typically involves clinic visits, testing, and possible collection of tissue or blood samples for research.
Who could benefit from this research
Good fit: Adult patients receiving cancer care at Ohio State with solid tumors or hematologic (blood) malignancies are the most likely candidates.
Not a fit: People not treated at Ohio State, children, or patients whose cancer type isn't included in available NCTN trials are less likely to benefit directly.
Why it matters
Potential benefit: You could get access to more NCI-sponsored trials and newer treatment options sooner than through standard care alone.
How similar studies have performed: The NCI's NCTN has supported many successful cancer trials in the past, so this effort builds on an established, effective network model.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Verschraegen, Claire F. — Ohio State University
- Study coordinator: Verschraegen, Claire F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.